UPI: Promising pancreatic cancer treatment

Media highlights potential new cancer therapy that could be in clinical trials soon

A new multi-drug combination therapy for pancreatic cancer is inching toward clinical trials in humans, according to University of Cincinnati researchers.

The drug compound, called SapC-DOPS, combines chemotherapy with targeted therapy and is capable of killing the cells that cause a number of cancers, including pancreatic cancer, which is notoriously difficult to treat.

"Based on pre-clinical studies, it has the potential to improve pancreatic cancer treatment," Xiaoyang Qi, PhD, a professor of hematology oncology at the University of Cincinnati College of Medicine and member of the UC Cancer Center. Qi is a lead author on the study which was published in the academic journal Molecular Therapy.

Read the full story.

Read the UC news release.

The Cincinnati Enquirer also covered this research.

Featured photo of pancreatic cancer cells courtesy of National Institutes of Health. Credit/Min Yu/Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC

Next Lives Here

The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.

Related Stories

1

Cincinnati sees record rainfall in weekend deluge

July 21, 2026

The Cincinnati Enquirer talks to UC College of Engineering and Applied Science Associate Professor Patrick Ray for context about a July 17 rainstorm that dumped a record amount of rain on parts of Cincinnati.

2

Putting preschool into perspective

July 20, 2026

Preschool and childcare can be difficult to navigate for parents, as Spectrum News 1 Ohio recently reported. Waitlists are long, and factors like cost, location and transportation can limit options. According to a recent study published by The Annie E. Casey Foundation, only 41% of 3- to 4-year-olds in Ohio were enrolled in preschool between 2020 and 2024 — a 4% decrease from pre-pandemic numbers. For University of Cincinnati early childhood education faculty member Chad Nunamaker, that statistic has caveats.

3

Ticks that survive pesticides can withstand colder winters

July 17, 2026

Ticks that survive less-than-lethal doses of pesticide are able to withstand dangerous cold, which could help them expand their range farther north, according to researchers at the University of Cincinnati and the U.S. Department of Agriculture.